PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.
We are constantly growing and developing our organization. As part of this process, we provide our employees with a dynamic and stimulating workplace with great opportunities to grow. PolyPeptide offers diverse opportunities for both experts and young professionals throughout the world.
Key information
- 200000 employees
- Neuhofstrasse 24, Baar
New jobs directly in your mailbox?
Currently, there are no job offers. Follow this company, and we’ll inform you by email as soon as new jobs become available.
No reviews yet
Help others by sharing your experience with this company as an employee or a candidate.